<?xml version="1.0" encoding="UTF-8"?>
<p>The availability of a licensed vaccine poses different challenges to current dengue control programs since it is not expected to vaccinate all the susceptibles and at-risk populations or even provide complete vaccine coverage in target groups. Vaccine introduction will therefore be a gradual process. In each of these populations several questions need to be addressed regarding the clinical spectrum and transmission risks in order to target vaccination to provide the most benefit [
 <xref rid="pntd.0006847.ref025" ref-type="bibr">25</xref>].
</p>
